Related Experiment Videos
Assessing patients with lupus: towards a drug responder index
1Centre for Rheumatology/Bloomsbury Rheumatology Unit, Middlesex Hospital, London.
Rheumatology (Oxford, England)
|November 11, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Operational changes to the lupus intervention fatigue trial as a result of COVID-19: An update to the study protocol.
Contemporary clinical trials communications·2023
Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients.
Arthritis care & research·2017
Clinical characteristics and long-term outcomes in SLE-myositis overlap syndrome: a controlled retrospective cohort study.
Rheumatology (Oxford, England)·2026
Patterns and changes in lifestyle habits of patients with rheumatoid arthritis during the first three years post-diagnosis.
Rheumatology (Oxford, England)·2026
Cross-sectional stroke risk identification in rheumatoid arthritis: integrating traditional and disease-specific factors.
Rheumatology (Oxford, England)·2026
DNA hypo-methylation of the TNFΑ gene predicts response to methotrexate in rheumatoid arthritis but not in psoriatic arthritis.
Rheumatology (Oxford, England)·2026
68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.
Rheumatology (Oxford, England)·2026
Antifungal activities and in silico prediction of Moringa oleifera Lam. fractions of leaves against Candida albicans.
Journal of advanced pharmaceutical technology & research·2026
Synthesis and structure-activity relationships of small-molecule 2-pyridone based CBX7 inhibitors.
RSC medicinal chemistry·2026
Fourier-transform infrared fingerprinting with chemometrics characterizes the anti-inflammatory activity of Rhizophora mucronata leaf fractions and profiles the active-fraction metabolites using liquid chromatography-high-resolution mass spectrometry analysis.
Journal of advanced pharmaceutical technology & research·2026
Predicting Antileishmanial Activity of Plant-Derived Compounds Using Random Forest Modeling.
microPublication biology·2026